Syros Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Syros Pharmaceuticals is a daily existence sciences organization that is centered around treating infection by planning quality administrative circuits and balancing the elements that direct quality articulation. Syros has spearheaded world-driving quality control examination and medication disclosure capacities with a demonstrated capacity to coordinate illness science and genomic information - a capability that isn't very much addressed in drug R&D. Key to the Syros approach is a restrictive foundation of painstakingly coordinated measure innovations, bioinformatics, and biologic bits of knowledge created by individuals from Syros' senior initiative. While this logical methodology has applications in numerous remedial regions, Syros has shown achievement at first in oncology, where it might help address various neglected clinical requirements.
Syros Pharmaceuticals has raised $130M across 1 funding round on record, the most recent a Post-IPO Equity of $130M announced in Jul 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Syros Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Syros Pharmaceuticals Funding Rounds
Syros Pharmaceuticals Founders and Leadership Team
Contact details for the Syros Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Syros Pharmaceuticals Funding Compared to Other Biotechnology Startups
Syros Pharmaceuticals' latest round of $130M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Syros Pharmaceuticals in Biotechnology and Watertown
Companies Similar to Syros Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Syros Pharmaceuticals Funding FAQs
What does Syros Pharmaceuticals do?
Syros Pharmaceuticals is a daily existence sciences organization that is centered around treating infection by planning quality administrative circuits and balancing the elements that direct quality articulation. Syros has spearheaded world-driving quality control examination and medication disclosure capacities with a demonstrated capacity to coordinate illness science and genomic information - a capability that isn't very much addressed in drug R&D. Key to the Syros approach is a restrictive foundation of painstakingly coordinated measure innovations, bioinformatics, and biologic bits of knowledge created by individuals from Syros' senior initiative. While this logical methodology has applications in numerous remedial regions, Syros has shown achievement at first in oncology, where it might help address various neglected clinical requirements.
How much funding has Syros Pharmaceuticals raised?
Syros Pharmaceuticals has raised $130M across 1 round on record. The most recent is a Post-IPO Equity of $130M announced in Jul 2022.
When did Syros Pharmaceuticals last raise funding?
Syros Pharmaceuticals' most recent funding round on record is a Post-IPO Equity of $130M, announced in Jul 2022.
Who is the CEO of Syros Pharmaceuticals?
Nancy Simonian is listed as CEO at Syros Pharmaceuticals.
Where is Syros Pharmaceuticals headquartered?
Syros Pharmaceuticals is based in Watertown, Massachusetts, United States.
How many employees does Syros Pharmaceuticals have?
Syros Pharmaceuticals is in the 101-250 employee band.
How does Syros Pharmaceuticals' funding compare to other Biotechnology startups?
Syros Pharmaceuticals' latest round of $130M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Syros Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Syros Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.